Clinical Controversies: Screening, Patch Testing & Physician Burnout

Population-based skin cancer screening fails to demonstrate a significant reduction in melanoma mortality, indicating that future efforts should prioritize risk-stratified approaches over universal exams. Clinical practice faces mounting pressure from a 153% increase in patient portal messaging, which, alongside unrealistic expectations fueled by direct-to-consumer advertising, contributes significantly to physician burnout and early career attrition. Meanwhile, therapeutic advancements offer new solutions: Nemolizumab provides effective pruritus control for cancer and cutaneous T-cell lymphoma patients, often allowing for as-needed dosing, while JAK inhibitors prove highly potent at suppressing patch test reactions. Furthermore, the rising prevalence of *Trichophyton indotiniae*—a resistant dermatophyte—necessitates extended treatment durations and the consideration of alternative antifungals like itraconazole, as standard terbinafine regimens frequently fail to clear these inflammatory, widespread infections.